Australian biotech firm makes stem cell breakthrough
Australia | News | By BioSpectrum Bureau | 0 Comment | 19 Feb, 2015
Singapore: Australia-based Cynata Therapeutics has made a breakthrough by devising a technique to mass manufacture stem ...Read more
Translation of ideas is Australia's key to growth'
Australia | Analysis | By BioSpectrum Bureau | 4 Comment | 30 Sep, 2014
Over the past decade the world's centre of economic gravity has shifted from US and Europe to Asia at a speed and scale ...Read more
CSL to expand its Melbourne plant
Australia | News | By BioSpectrum Bureau | 0 Comment | 09 Oct, 2014
Singapore: CSL announced that it has clinched a deal with the Victorian government to expand its Melbourne plasma manufa...Read more
TGA approves Telezon's SoloFlow
Australia | News | By BioSpectrum Bureau | 0 Comment | 18 Oct, 2013
Singapore: Telezon's flagship SoloFlow Reconstitution Needle (polymer needle) has been accepted by Therapeutic Goods Aus...Read more
Allied commences Cardiocel sale in Europe
Australia | News | By BioSpectrum Bureau | 0 Comment | 08 Nov, 2013
Singapore: Australia based Allied Healthcare has started commercializing CardioCel into Europe after the Company receive...Read more
China and Australia grant patent to NBB nicotine biosynthesis gene
Australia | Regulatory | By BioSpectrum Bureau | 1 Comment | 10 Jul, 2012
Singapore: 22nd Century Group, a company that has developed pioneering technology for tobacco harm reduction and smoking...Read more
Australia grants $7 mn to uplift cancer research
Australia | News | By BioSpectrum Bureau | 0 Comment | 11 May, 2015
Singapore: Cancer Council NSW, Australia's non-government cancer research funder, has granted almost $7 million to resea...Read more
Novogen progresses on drug for paediatric brain cancer
Australia | News | By BioSpectrum Bureau | 0 Comment | 08 May, 2015
Singapore: US-Australian drug discovery company, Novogen, in conjunction with Australian paediatric cancer researchers, ...Read more
Novogen develops drug to enhance chemotherapy effect
Australia | News | By BioSpectrum Bureau | 0 Comment | 15 Jul, 2015
Singapore: Australian drug discovery company, Novogen, has developed anti-tropomyosin drug candidate, Anisina, which has...Read more
Eloxatin shows +ve results in tumor inhibition
Australia | News | By BioSpectrum Bureau | 0 Comment | 11 Sep, 2013
Singapore: Australia-based Starpharma Holdings has achieved improved tumor-inhibiting efficacy and reduced overall toxic...Read more
Biosensis introduces new ELISA kits
Australia | News | By BioSpectrum Bureau | 0 Comment | 24 Nov, 2014
Singapore: Biosensis has announced the launch of its new range of Rapid ELISA kits. The company has released fifteen new...Read more
Oxycodone patch resumes clinical development
Australia | News | By BioSpectrum Bureau | 0 Comment | 05 Apr, 2013
Singapore: Australian drug delivery technology company, Phosphagenics, will be returning to the clinic with its oxycodo...Read more
Lack of funding-A major healthcare challenge
Australia | News | By BioSpectrum Bureau | 0 Comment | 09 Jun, 2015
Singapore: An extensive study commissioned by Polycom, a global service provider, highlighted that lack of funding and g...Read more
Starpharma appoints Robert Thomas as board member
Australia | News | By BioSpectrum Bureau | 0 Comment | 11 Nov, 2013
Singapore: Australia based pharmacuetical company, Starpharma, has appointed Mr Robert Thomas to the Board as a non-exec...Read more
Australia supports budding medical researchers
Australia | News | By BioSpectrum Bureau | 0 Comment | 11 May, 2015
Singapore: Australia's Balnaves Foundation has donated $450,000 to the University of Sydney's medical school to help pro...Read more
TGA approves chemotherapy-induced nausea and vomiting drug
Australia | News | By BioSpectrum Bureau | 0 Comment | 11 May, 2015
Singapore: Australian biopharmaceutical company, Specialised Therapeutics Australia (STA), and Helsinn, a Swiss group fo...Read more
Study: Drinking coffee can make you fat
Australia | News | By BioSpectrum Bureau | 0 Comment | 29 May, 2013
Singapore: A study conducted by Australian researchers from the Western Australian Institute for Medical Research (WAIMR...Read more
Celgene to acquire Mesoblast shares at $45 mn
Australia | News | By BioSpectrum Bureau | 0 Comment | 15 Apr, 2015
Singapore: US based Celgene Corporation, a global biopharmaceutical, has agreed to acquire shares of Australia's regener...Read more